Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Material agreement · Unregistered share sale
  7. 10-Q Report Quarterly Report
  8. 8-K Event Regulation FD disclosure
  9. CT ORDER Other Confidential Order
  10. 8-K Event Executive or director change
  11. CT ORDER Other Confidential Order
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Executive or director change · Shareholder vote results
  17. 424B3 Offering Prospectus
  18. 8-K Event Material agreement
  19. 8-K Event Regulation FD disclosure
  20. 4 Insider Changes in Ownership

Page 34 of 72 · 1,429 filings